Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025

Conference Call to be Held at 8:30 a.m. ET CHICAGO --(BUSINESS WIRE)--Oct. 23, 2025-- Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today